| Code | 4931D | ||||||||||
| MA number | 18/0149/20-S | ||||||||||
| Product Form: | tbl 112x50 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Accord Healthcare Polska Sp. z o.o., Poland | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 01.07.2020 |
| Validity: | 01.07.2025 |
| MA renewed: | Renewal application submitted |
| SPC: |
SPC_Vildagliptin Accord 50 mg tablety_02.2024.pdf
|
| PIL: |
PIL_Vildagliptin Accord 50 mg tablety_02.2024.pdf
|
| Safety feature | Yes |
| Data update: | 22.02.2024 |
